Laurion Capital Management LP Atea Pharmaceuticals, Inc. Transaction History
Laurion Capital Management LP
- $5.23 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding AVIR
# of Institutions
113Shares Held
52.4MCall Options Held
7.6KPut Options Held
19K-
Black Rock Inc. New York, NY9.12MShares$27 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN7.61MShares$22.5 Million18.41% of portfolio
-
Tang Capital Management LLC San Diego, CA4.79MShares$14.2 Million1.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$14 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.49MShares$7.36 Million2.49% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $246M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...